In complex neurological diseases, such as multiple sclerosis, stroke or spinal cord injuries, a treatment with stem cells may be the sole remaining choice of cure

Find out more


The World’s Lightest and Smartest “Wear-and-Forget” Companion Device for Ambient Assisted Living

Find out more


To provide innovation in high-tech fields/high-growth sectors requiring multi-disciplinary approaches and know-how.
from bio-electronics, smart sensors and systems to advanced solutions for nano-medicine, cell-therapies, and drug delivery.


Our vision is to innovate within both the health care and medical fields by repositioning state of the art technologies in order to improve people’s quality of life and cost of care.


We provide research & development expertise and hands-on experience to support feasibility studies and business innovation.

We work with an experienced team of designers and expert engineers, medical advisors, biologists, material scientists and project managers, allocated as technical staff to each project. This allows an effective and sustainable way to achieve the project goals timely and with the right focus.

We work with third parties in a foundry-based manufacturing scheme to scale-up the products into the global market.

View More


In the latest issue of Cell CITC Ltd preview a significant new paper by Jeppesen et al. reassessing the composition of extracellular vesicles

Cambridge, 11 th April 2019 – CITC’s own Stefano Pluchino and Jayden Smith have published in Cell an invited article Explicating Exosomes: Reclassifying the Rising Stars of Intercellular Communication , in which they preview an important new paper from Robert J. Coffey’s lab at Vanderbilt University that re-examines the biomolecular composition of exosomes.

Read More

CITC shares its experience following 18 months of participation in the CUPIDO project targeting new treatments for Cardiovascular Diseases

Cambridge 13th March 2019 - The EU-funded project, CUPIDO, which started in February 2017, proposes the application of nanotechnologies to target cardiovascular disease. Exploiting such a tiny system as a route of administration can revolutionise the cardiovascular field, becoming the first non-invasive and heart-specific therapy.

Read More

"RESTORE Health by Advanced Therapies" to become billion-euro 'flagship'

Cambridge, 4th March 2019 - We are delighted to announce that the consortium "RESTORE Health by Advanced Therapies” has been selected to compete to become one of the European Commission’s next billion-euro ‘flagship’ science initiatives.

The Large Scale Research Initiative RESTORE will be a “place” where medicine, basic research, technology development and engineering meet, communicate and work together: to tackle grand interdisciplinary science and technology challenges and to find novel solutions. 

Read More

CITC Ltd awarded with an Innovate UK Health and Life Sciences competition grant for their humaNase project

Cambridge, 2nd August 2018 - Innovate UK , the UK’s innovation agency has awarded CITC Ltd funding for their humaNase project to investigate the potential of novel chemotherapies.

A powerful therapeutic strategy against some cancers, notably Acute Lymphoblastic Leukaemia (ALL), has been to starve the cells of ASN by utilizing the enzyme L-asparaginase (ASNase) which converts ASN to aspartate which cannot be used by cancerous cells.

Read More

© Copyright 2019 Cambridge Innovation Technologies Consulting LtdWeb Design By Toolkit Websites